{"id":1866,"date":"2020-01-09T17:50:12","date_gmt":"2020-01-09T22:50:12","guid":{"rendered":"https:\/\/cqdm.org\/en\/news-and-events\/project-funded-through-cqdm-will-explore-potential-of-fusion-genomics-onetest-to-improve-diagnosis-of-respiratory-tract-infections\/"},"modified":"2024-09-25T16:27:31","modified_gmt":"2024-09-25T20:27:31","slug":"project-funded-through-cqdm-will-explore-potential-of-fusion-genomics-onetest-to-improve-diagnosis-of-respiratory-tract-infections","status":"publish","type":"post","link":"https:\/\/cqdm.org\/en\/news-and-events\/project-funded-through-cqdm-will-explore-potential-of-fusion-genomics-onetest-to-improve-diagnosis-of-respiratory-tract-infections\/","title":{"rendered":"Project funded through CQDM will explore potential of Fusion Genomics\u2019 ONETest\u2122 to improve diagnosis of respiratory tract infections"},"content":{"rendered":"\n<p>We&#8217;re delighted to announce that Fusion Genomics has been awarded $1 million to conduct a prospective clinical study evaluating its product: ONETest\u2122. The project will be funded through our Quantum Leap program with support from Merck and will explore the improvement for diagnosis of respiratory tract infections.<\/p>\n\n\n\n<p>Fusion Genomics ONETest\u2122 is a highly sensitive, cost-effective next-generating sequencing-based assay capable of simultaneously detecting approximately 1,400 known human infections in a single test. CQDM is proud to support the evaluation of this test to identify pathogens responsible for respiratory tract infections, which are a leading cause of morbidity, mortality, and hospitalizations globally. This project will enable faster diagnostics, that could be useful in emergencies and clinics.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.businesswire.com\/news\/home\/20200109005279\/en\/Fusion-Genomics-Receives-1-Million-Award-Evaluate\" target=\"_blank\" rel=\"noopener\">Read Fusion Genomics&#8217; press release<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>We&#8217;re delighted to announce that Fusion Genomics has been awarded $1 million to conduct a prospective clinical study evaluating its product: ONETest\u2122. The project will be funded through our Quantum Leap program with support from Merck and will explore the improvement for diagnosis of respiratory tract infections. Fusion Genomics ONETest\u2122 is a highly sensitive, cost-effective&hellip;<\/p>\n","protected":false},"author":2,"featured_media":1093,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1866","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-our-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/1866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/comments?post=1866"}],"version-history":[{"count":1,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/1866\/revisions"}],"predecessor-version":[{"id":4321,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/posts\/1866\/revisions\/4321"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media\/1093"}],"wp:attachment":[{"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/media?parent=1866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/categories?post=1866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cqdm.org\/en\/wp-json\/wp\/v2\/tags?post=1866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}